160 related articles for article (PubMed ID: 22012030)
1. Efficacy of plasma rich in growth factors for the treatment of dry eye.
López-Plandolit S; Morales MC; Freire V; Grau AE; Durán JA
Cornea; 2011 Dec; 30(12):1312-7. PubMed ID: 22012030
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic dry eye treatment with autologous platelet-rich plasma.
Alio JL; Colecha JR; Pastor S; Rodriguez A; Artola A
Ophthalmic Res; 2007; 39(3):124-9. PubMed ID: 17374962
[TBL] [Abstract][Full Text] [Related]
3. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome.
Yoon KC; Im SK; Park YG; Jung YD; Yang SY; Choi J
Cornea; 2006 Apr; 25(3):268-72. PubMed ID: 16633024
[TBL] [Abstract][Full Text] [Related]
4. The treatment of severe trachomatous dry eye with canalicular silicone plugs.
Guzey M; Ozardali I; Kilic A; Basar E; Dogan Z; Satici A; Karadede S
Eye (Lond); 2001 Jun; 15(Pt 3):297-303. PubMed ID: 11450724
[TBL] [Abstract][Full Text] [Related]
5. Plasma Rich in Growth Factors for the Treatment of Dry Eye after LASIK Surgery.
Sanchez-Avila RM; Merayo-Lloves J; Fernandez ML; Rodriguez-Gutierrez LA; Jurado N; Muruzabal F; Orive G; Anitua E
Ophthalmic Res; 2018; 60(2):80-86. PubMed ID: 29886478
[TBL] [Abstract][Full Text] [Related]
6. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects.
López-Plandolit S; Morales MC; Freire V; Etxebarría J; Durán JA
Cornea; 2010 Aug; 29(8):843-8. PubMed ID: 20508516
[TBL] [Abstract][Full Text] [Related]
7. PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model.
Anitua E; Muruzabal F; de la Fuente M; Riestra A; Merayo-Lloves J; Orive G
Exp Eye Res; 2016 Oct; 151():115-21. PubMed ID: 27567559
[TBL] [Abstract][Full Text] [Related]
8. Impact of Plasma Rich in Growth Factors (PRGF) Eye Drops on Ocular Redness and Symptomatology in Patients with Dry Eye Disease.
Lozano-Sanroma J; Barros A; Alcalde I; Sánchez-Ávila RM; Queiruga-Piñeiro J; Fernández-Vega Cueto L; Merayo-Lloves J
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241160
[No Abstract] [Full Text] [Related]
9. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
[TBL] [Abstract][Full Text] [Related]
10. Relationship of impression cytology and tear ferning to reports of dry eye.
Jackson JA; Perrigin JA
J Am Optom Assoc; 1999 Mar; 70(3):187-92. PubMed ID: 10457694
[TBL] [Abstract][Full Text] [Related]
11. A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America.
Soifer M; Tovar A; Wang M; Mousa HM; Yennam S; Sabater AL; Pflugfelder SC; Perez VL
Ocul Surf; 2022 Jul; 25():40-48. PubMed ID: 35489588
[TBL] [Abstract][Full Text] [Related]
12. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
Kim EC; Choi JS; Joo CK
Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
[TBL] [Abstract][Full Text] [Related]
13. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
[TBL] [Abstract][Full Text] [Related]
14. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery.
Li XM; Hu L; Hu J; Wang W
Cornea; 2007 Oct; 26(9 Suppl 1):S16-20. PubMed ID: 17881910
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome.
Sanchez-Avila RM; Merayo-Lloves J; Riestra AC; Anitua E; Muruzabal F; Orive G; Fernández-Vega L
J Ocul Pharmacol Ther; 2017 Jun; 33(5):391-399. PubMed ID: 28375790
[TBL] [Abstract][Full Text] [Related]
16. [Impression cytology study of dry eyes in patients with congenital aniridia].
Rivas L; Murube J; Rivas A; Murube E
Arch Soc Esp Oftalmol; 2003 Nov; 78(11):615-22. PubMed ID: 14648368
[TBL] [Abstract][Full Text] [Related]
17. Conjunctival impression cytology in dry eye states.
Reddy M; Reddy PR; Reddy SC
Indian J Ophthalmol; 1991; 39(1):22-4. PubMed ID: 1894340
[TBL] [Abstract][Full Text] [Related]
18. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.
Russo PA; Bouchard CS; Galasso JM
Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749
[TBL] [Abstract][Full Text] [Related]
19. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients.
Di Pascuale MA; Goto E; Tseng SC
Ophthalmology; 2004 Apr; 111(4):783-91. PubMed ID: 15051213
[TBL] [Abstract][Full Text] [Related]
20. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.
Matsuo T
Jpn J Ophthalmol; 2004; 48(4):321-7. PubMed ID: 15295655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
